Effectiveness of clozapine and a social learning program for severely disabled psychiatric inpatients

Psychiatric Services

Volumn 47, Issue 1, 1996, Pages 46-51

  Menditto, Anthony A ^a,b   Beck, Niels C ^c   Stuve, Paul ^c   Fisher, Judith A ^a,c   Stacy, Mark ^c   Logue, Mary Beth ^c   Baldwin, Lee J ^c  

^a Fulton State Hospital   (United States)

^b University of Missouri   (United States)

^c Department of Psychiatry ^*

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE;

ADULT; AGGRESSION; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CLINICAL FEATURE; DATA ANALYSIS; DISABILITY; DISEASE SEVERITY; DOPAMINE RELEASE; HOSPITAL PATIENT; HUMAN; MALE; PATIENT COMPLIANCE; PATIENT MONITORING; SCHIZOPHRENIA; TREATMENT PLANNING;

EID: 0030060056     PISSN: 10752730     EISSN: None     Source Type: Journal    
DOI: 10.1176/ps.47.1.46     Document Type: Article

References (32)

1. Meltzer HY: An overview of the mechanism of action of clozapine. Journal of Clinical Psychiatry 55(Sept suppl B):47-52, 1994
2. Moghaddam B: Preferential activation of cortical dopamine neurotransmission by clozapine: functional significance. Journal of Clinical Psychiatry 55(Sept suppl B).27-29, 1994
3. Breier A, Buchanan RW, Irish D, et al. Clozapine treatment of outpatients with schizophrenia: outcome and long-term response patterns. Hospital and Community Psychiatry 44:1145-1149, 1993
4. Kane J, Honigfeld G, Singer J, et al: Clozapine for treatment-resistant schizophrenia. a double-blind comparison with chlorpromazine. Archives of General Psychiatry 45.789-796, 1988
5. Meltzer HY, Burnett S, Bastani B, et al: Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients Hospital and Community Psychiatry 41.892-897, 1990
6. Meltzer HY: Dimensions of outcome with clozapine. British Journal of Psychiatry 160(suppl 17):46-53, 1992
7. Wilson WH, Claussen AM: 18-month outcome of clozapinc treatment for 100 patients in a state psychiatric hospital. Psychiatric Services 46.386-339. 1995
8. Kane JM, Safferman A, Pollack S, et al: Clozapine, negative symptoms, and evtrapyramidal side effects. Journal of Clinical Psychiatry 55(Sept suppl B):74-77, 1994
9. Chiles JA, Davidson P, McBride D. Effects of clozapine on use of seclusion and restraint at a state hospital. Hospital and Community Psychiatry 45.269-271, 1994
10. Ebrahim GM, Gibler B, Gacuno CB. et al: Patient response to clozapine in a forensic psychiatric hospital. Hospital and Community Psychiatry 45:271-273 1994
11. Mallya AR, Roos PD, Roebuck-Colgan K: Restraint, seclusion, and clozapine. Journal of Clinical Psychiatry 33:395-397, 1992
12. Ratay J, Leveroni C, Kilmer D, et al The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital. Journal of Clinical Psychiatry 54:219-223, 1993
13. Wilson WH: Clinical review of clozapine treatment in a state hospital. Hospital and Community Psychiatry 47:700-703, 1992
14. Fuoco FJ, Tyson WM: Behavior therapy in residential programs for psychiatric clients, in Behavior Analysis and Therapy in Residential Programs. Edited by Fuoco FJ, Christian WP. New York, Van Nostrand Reinhold, 1986
15. Glynn SM: Token economy approaches for psychiatric patients: progress and pitfalls over 25 years. Behavior Modification 14:383-407, 1990
16. Glynn S, Mueser KT: Social learning for chronic mental patients Schizophrenia Bulletin 12.648-668, 1986
17. Kazdin AE: The token economy in Evaluating Behavior Therapy Outcome Edited by Turner R. Asher LM New York, Springer, 1985
18. Liberman RP (ed): Psychiatric Rehabilitation of Chronic Mental Patients. Washington, DC, American Psychiatric Press, 1988
19. Paul GL, Lentz RJ: Psychosocial Treatment of Chronic Mental Patients. Milieu Versus Social Learning Programs. Cambridge, Mass. Harvard University Press, 1977
20. Paul GL, Menditto AA: Effectiveness of inpatient treatment programs for mentally ill adults in public psychiatric facilities. Applied and Preventive Psychology 1.41-63, 1992
21. Beck XC, Menditto AA, Baldwin L, et al: Reduced frequency of aggressive behavior in forensic patients in a social learning program. Hospital and Community Psychiatry 42.750-752, 1991
22. Menditto AA, Baldwin LJ, O'Neal LG, et al: Social learning procedures for increasing attention and teaching basic skills to severely regressed and chronically institutionalized forensic psychiatric patients. Journal of Behavior Therapy and Experimental Psychiatry. 22:265-269, 1991
23. Baldwin LJ, Menditto AA, Beck NC, et al: Decreasing excessive water drinking behavior by chronic mentally ill forensic patients Hospital and Community Psychiatry 43:507-509, 1992
24. Menditto AA, Valdez L, Beck NC: Implementing a comprehensive social learning program within the forensic psychiatric service of Fulton State Hospital, in Behavior Therapy in Psychiatric Hospitals. Edited by Corrigan PW, Liberman RP. New York, Springer. 1994
25. Paul GL (ed): Observational Assessment Instrumentation for Service and Research: The Time-Sample Behavioral Checklist: Assessment in Residential Treatment Settings, Part 2. Champaign, Ill, Research Press, 1987
26. Paul GL, Power CT, Engel KL, et al: The Time-Sample Behavioral Checklist observer manual, ibid
27. Licht MH, Paul GL Replicability of TSBC codes and higher-order scores, ibid
28. Mariotto MJ, Paul GL, Licht MH: Concurrent relationships of TSBC higher-order scores with information from other instruments, ibid
29. Paul GL, Mariotto MJ. Predictive relationships of TSBC higher-order scores to other measures of performance and outcomes, ibid
30. Menkes DB, Clarkson HO, Caradoc-Davies G, et al. Anticholinergic equivalents and parkinsonisin: a model for predicting side-effects of antipsychotic drugs. International Clinical Psychopharmacology 2:55- 67, 1987
31. McNeil Pharmaceuticals: Haldol Decanoate Prescribing Information. Spring House, Pa, McNeilab, 1992
32. Schatzberg AE Cole JO: Manual of Clinical Psychopharmacology. Washington, DC, American Psychiatric Press, 1986